STOCK TITAN
  1. Home
  2. News
  3. NAMSW

NewAmsterdam Pharma Company N.V. Warrant (NAMSW) Stock News, Sep 2023-Feb 2024

NAMSW NASDAQ
News

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in March

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.13%
Tags
conferences
-
News

NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
offering
-
News

NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
offering
News

NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
News

NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.08%
Tags
management
-
News

NewAmsterdam Pharma Announces 2024 Strategic Priorities

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.59%
Tags
none
News

NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter 2023 Financial Highlights

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.72%
Tags
earnings
-
News

NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.76%
Tags
management
-
News

NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients with Early Alzheimer’s Disease Who Carry an ApoE4 Mutation

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.99%
Tags
clinical trial
News

NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.88%
Tags
conferences

FAQ

What is the current stock price of NewAmsterdam Pharma Company N.V. Warrant (NAMSW)?

NewAmsterdam Pharma Company N.V. Warrant (NAMSW) last closed at $8.25.